Virtual Tour Of LifeLine (VR-360)
Haematologica February 2016 : Doi:10.3324/haematol.2015.138594
Abstract
Umbilical cord blood stem cell transplants are commonly used in adults lacking HLA-identical donors. Delays in hematopoietic recovery contribute to mortality and morbidity. To hasten recovery we used co-infusion of progenitor cells from a partially matched related donor and an UCB (haplo-cord transplant).
International stem cell scientists, co-led in Canada by Dr. John Dick and in the Netherlands by Dr. Gerald de Haan, have discovered the switch to harness the power of cord blood and potentially increase the supply of stem cells for cancer patients needing transplantation therapy to fight their disease.
Elham, a 12-year-old girl from Isfahan, Iran, was diagnosed with the ALL form of leukemia in 2014. Since then she underwent chemotherapy three times as the main treatment method, but it turned out to be all in vain. She was cured by a stem cell transplant from her baby sister’s umbilical cord blood.
Charecteristics of Stem Cells
Umbilical cord blood transplantation can improve neurologic outcomes in the short term if performed before symptoms appear, but long-term outcomes are unknown.
The findings demonstrate that "HSCT performed before the onset of severe symptoms delays disease progression and improves both length and quality of life" over the long term, the study authors, led by Matthew D. Wright, MD, of the program for the study of neurodevelopment in rare disorders at the University of Pittsburgh in Pittsburgh, PA, wrote.
Julie Robotham, Medical Editor
STEM cells would be harvested from the placentas and umbilical cords of newborn babies, under a plan Australian researchers say could yield therapies for conditions ranging from arthritis to burns. But other doctors say the proposed service - costing families about $5000 - preys on the fears of new parents and has insufficient scientific backing...
We are at the cusp of a stem cell revolution.
Understanding and harnessing these unique cells may unlock breakthroughs in longevity and therapeutic solutions to all kinds of chronic diseases and regenerative opportunities.
The recent clinical progress that has been made in the medical space of stem cell transplantation is that now cord blood is considered as a better source than bone marrow cells. This was found in a research study based in US, published in 2020.
December 27, 2020, 21:46 IST
The umbilical cord is a connection between the fetus and the placenta. The components of the cord are umbilical arteries, vein, and jelly. The blood in the umbilical cord at birth is usually rich in stem cells. The stem cells are referred to as hematopoietic stem cells. These stem cells are capable of growing into different kind of blood cells; erythrocytes, leucocytes, and platelets. The umbilical stem cells have been useful in the treatment of many hematological and non- hematological diseases. They have also been very useful to researchers. The procedure of collecting the blood does not inconvenience the mother or the newborn in any way. However, they are extracted with the permission of the presence of the baby. In fact, this same blood is normally discarded as waste after delivery.
Blood is a specialized fluid in your body that has four main components, each with a different function: plasma, red blood cells, white blood cells, and platelets. Watch this video to learn more about how these components work.
Parents have a unique opportunity in their lives to decide to keep the stem cells of their newborn babies, as the last ones contained in the umbilical cord and which can not be collected in another phase of human life are the “key” for treating a multitude of diseases.
Science Daily
A CD26 Inhibitor increases the efficiency and responsiveness of umbilical cord blood for bone marrow transplants and may improve care for blood cancer patients according to research from Rush University Medical Center being presented at the 6th Annual International Umbilical Cord Blood Transplantation Symposium, June 6-7 in Los Angeles...
British scientists have made the first human embryonic stem cells of a high enough grade to use in patients and deposited them in a public stem cell bank for development in human trials by drug companies and researchers by 2014.
Findings of the Duke University Pediatric Blood and Marrow Transplant Program and the Robertson Clinical and Translational Therapy research endeavor concluded that an infusion of cells from a child’s own umbilical cord blood appears to improve brain connectivity and motor function.
The reassuring conclusion of the Cryo-Cell study is that cord blood units collected from multiple births have sufficient numbers of stem cells to treat children for cerebral palsy and other conditions identified in infancy, under current dosing guidelines.
A video about the Types Of Blood Cells.
Does the key to improving the lives of children with autism lie in their own umbilical cord blood? The answer may be yes, according to a new study by Duke researchers.
Scientists conducted an investigation to determine whether infusing an autistic child with blood from the umbilical cord would reduce symptoms of autism.
+ Author Affiliations
Abstract
Umbilical cord blood is an alternative hematopoietic stem cell source for patients with hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation. Initially, umbilical cord blood transplantation was limited to children, given the low cell dose infused. Both related and unrelated cord blood transplants have been performed with high rates of success for a variety of hematologic disorders and metabolic storage diseases in the pediatric setting.
Karen K. Ballen,1 Eliane Gluckman,2 and Hal E. Broxmeyer3
During pregnancy, you'll need to decide what you want to do with your baby's cord blood. So what exactly is cord blood?